Alizzi, Z.; Roxburgh, P.; Cartwright, D.; McLaren, A.; Park, S.; Jones, R.; Greening, S.; Hudson, E.; Green, C.; Gray, S.;
et al. Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting. J. Clin. Med. 2023, 12, 2497.
https://doi.org/10.3390/jcm12072497
AMA Style
Alizzi Z, Roxburgh P, Cartwright D, McLaren A, Park S, Jones R, Greening S, Hudson E, Green C, Gray S,
et al. Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting. Journal of Clinical Medicine. 2023; 12(7):2497.
https://doi.org/10.3390/jcm12072497
Chicago/Turabian Style
Alizzi, Zena, Patricia Roxburgh, Douglas Cartwright, Alistair McLaren, Sarah Park, Rachel Jones, Semini Greening, Emma Hudson, Clare Green, Simon Gray,
and et al. 2023. "Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting" Journal of Clinical Medicine 12, no. 7: 2497.
https://doi.org/10.3390/jcm12072497
APA Style
Alizzi, Z., Roxburgh, P., Cartwright, D., McLaren, A., Park, S., Jones, R., Greening, S., Hudson, E., Green, C., Gray, S., Khalique, S., Karteris, E., & Hall, M.
(2023). Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting. Journal of Clinical Medicine, 12(7), 2497.
https://doi.org/10.3390/jcm12072497
